On the other hand, nano-delivery systems can enhance the tumor targeting of drugs through the enhanced penetration and retention (EPR) effect, and improve the bioavailability of hydrophobic drugs (such as CYP), and spatial–temporal synchronous release, thus improving the efficacy of antitumor drugs [27,28,29]. The gene discussed is PPIG; the disease is neoplasm.